alkahest


Also found in: Dictionary, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for alkahest

hypothetical universal solvent once sought by alchemists

References in periodicals archive ?
'This proof-of-concept study will increase our understanding of the biological activity of GRF6021, specifically its anti-inflammatory effects, which will guide potential applicability across different diseases states, including systemic conditions,' said Steven Braithwaite, Ph.D., chief scientific officer of Alkahest. 'Given the growing aging population, total knee and hip arthroplasties are increasingly common.
Alkahest intends to enroll approximately 45 subjects who will receive GRF6021 or placebo.
Alkahest acquired ALK4290 from Boehringer-Ingelheim and has exclusive rights for development and commercialization worldwide.
Privately-held Alkahest is focused on developing innovative therapies to treat age-related diseases, with an emphasis on neurodegeneration.
Spanish healthcare company Grifols (MCE: GRF) (NASDAQ: GRFS) and US-based biopharmaceutical company Alkahest have signed definitive agreements under which Grifols will make a major equity investment in Alkahest, and the companies will work together to develop novel plasma-based products for the treatment of cognitive decline in aging and disorders of the central nervous system, including Alzheimer's, the companies said on Wednesday.
Dhalgren can best be characterized by the words that Kid, the novel s protagonist, uses to characterize his own book of poems: "a complicitous illusion in lingual catalysis, a crystalline and conscientious alkahest."(1) This is the sort of language one would expect to find in contemporary criticism, not in a work of fiction, except that, since the advent of the postmodern, the borders between these ostensibly different sorts of texts, the creative and the critical, have been jumbled, if not abolished.
Release date- 05082019 - SAN CARLOS - Alkahest, Inc., a clinical-stage biotechnology company focused on developing transformative therapies to treat age-related diseases, today announced top-line data from its phase 2 clinical trial of its candidate GRF6019 in mild-to-moderate Alzheimer's disease dementia (AD).
Karoly Nikolich, chief executive officer of Alkahest. 'Developing impactful treatments for this disease and other neurodegenerative diseases of aging has proven unsuccessful for decades.
The trial, which was hosted at Stanford Hospital, was sponsored by California-based biotechnology company, Alkahest, which owns intellectual property associated with the treatment regimen.
Moving the research into human experiments will be difficult, but Wyss-Coray has started a biotechnology company, Alkahest, and plans to test the effects of plasma from young donors on people with Alzheimer's disease.
Alkahest Incorporated, a biotechnology company focused on developing innovative treatments for neurodegenerative diseases and other age-related conditions, announced yesterday that it has named Sam Jackson, MD, MBA as its chief medical officer
Dr Jackson will lead the translational and clinical development activities at Alkahest and serve on the Executive Leadership Team.
4 March 2015 - Spanish healthcare company Grifols (MCE: GRF) (NASDAQ: GRFS) and US-based biopharmaceutical company Alkahest have signed definitive agreements under which Grifols will make a major equity investment in Alkahest, and the companies will work together to develop novel plasma-based products for the treatment of cognitive decline in aging and disorders of the central nervous system, including Alzheimer's, the companies said on Wednesday.
Grifols will make a USD 37.5m equity investment in the form of a cash payment in exchange for 45% of Alkahest's shares following the closing of the transaction.
M2 EQUITYBITES-March 4, 2015-Spain's Grifols to Acquire 45% of US Biopharmaceutical Company Alkahest